20505 results for «»
20505 results
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578

Author

Meet the Team

LAA occlusion in reverse chicken-wing
04 Nov 2024
Discover the case of an 82-year-old female with cardiovascular risk factors including hypertension and diabetes (managed with oral antidiabetics), permanent non-valvular atrial fibrillation, who presented with recurrent episodes of epistaxis while on anticoagulants...

Author

Author

Author

TRISCEND II: implications on current clinical practice
09 Sep 2024
Watch the replay of this webinar with J. Dreyfus, A. Duncan, P. Lurz and V. Rudolph to understand the pros and cons of TTVR and much more!

2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases
09 Sep 2024
The 2024 ESC Guidelines for aortic diseases, merged with peripheral arterial disease guidelines, update prior guidance and emphasize atherosclerotic conditions. In this article, Antoine Sauguet summarizes the content related to peripheral arterial diseases.

Author

Pioneers in TAVI
09 Sep 2024
Meet some of the first generation of pioneers that have inspired many thousands of interventionalists and learn more about the many obstacles they were obliged to along their journey.

TAVI: a fascinating 20-year-long odyssey with a happy ending
10 Nov 2017
This new "disruptive" technology is among the most important medical breakthroughs to date. TAVI emerged in 2002 to profoundly alter the landscape of cardiovascular medicine.

#AictPCR 2025 Social Media Team

Flat-out success: TAVI in a patient with a horizontal aorta and large annulus
16 Oct 2024
Study the case of an 86-year-old male patient with progressive NYHA III dyspnoea, HTN, AF and previous stroke who presented with HF, LVEF 61 %, severe atrial dilatation, severe AS, mild MR and severely calcified tricuspid aortic valve with a large annulus suitable for transfemoral TAVI.

Author

Author

PCR Tricuspid Focus Group - referral meeting in Stockholm
19 Sep 2024
Join your peers for this meeting on 22 November 2024 in Stockholm, Sweden!

Harish Oruganti
Ongole, India
Mohamed Hamouda Elkasaby
Cairo, Egypt
Nikhil Singhania
Puducherry, India
Jaibharat Sharma
Mandi, India
Krishna Sahani
Lucknow, India
Zarrin Kang
Ipoh, Malaysia
Muralidhar Naik
BAGALKOT, India
Sujani Vinnakota
Hyderabad, India
Shiori Kawakami
Kobeshi, Japan
Shantanu Shantanu
Gurugram, India